News & Press Releases
Filter by:
Mintz Partners with A Good Option to Support Innovative Equity-Based Philanthropy Model
September 15, 2026
Mintz has partnered with A Good Option (AGO), a nonprofit organization advancing an innovative equity-based approach to charitable giving. Through the firm's pro bono program, Mintz is advising AGO on governance, equity donation structures, and other legal and operational matters as the organization expands.
Mintz Partner Lee Johnson, PhD, has been named Patent Strategy Practitioner of the Year in the 2026 LMG Life Sciences Americas Awards. The firm also received the Impact Deal of the Year – Canada award for its representation of Kye Pharmaceuticals in its licensing and distribution agreement with Neurim Pharmaceuticals for SLENYTO® in Canada.
Mintz Deepens Investment Funds Capabilities Across Financial Services and Emerging Technologies
September 09, 2026
NEW YORK – Mintz welcomes Mark Shaffer to the firm's Investment Funds Practice as a Member based in New York. With more than 20 years of experience advising clients across the financial services ecosystem, including private funds, fintech companies, broker dealers, and digital asset businesses, Mark further strengthens Mintz's market-leading capabilities in financial regulation, compliance, and emerging technologies.
Mintz Advises ZuriMED Shareholders in Acquisition by Stryker
September 08, 2026
Mintz is advising the shareholders of ZuriMED Technologies AG on US law matters in connection with the company's proposed acquisition by Stryker. The shareholder group comprises more than 100 institutional and private investors.
Mintz advised Affordable Wire Management (AWM), a leading provider of wire management, cable protection, and balance-of-system solutions for utility-scale solar and energy storage projects, in its acquisition by ARRAY Technologies.
Mintz Advises Antora Energy on $550M Series C Financing to Meet Rising Energy Demand
September 03, 2026
Mintz advised Antora Energy, a leading US energy storage company, on its $550 million Series C preferred stock financing.
